PSU19 Does the Novel Renal Marker NGAL (Neutrophil Gelatinase-Associated Lipocalin) Result in Cost Savings in Patients With Renal Impairment Following Cardiac Surgery?
Abstract
Authors
O. Stanger B. Bacher
O. Stanger B. Bacher
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now